Week 3 - Key reading Flashcards
1
Q
Espie 2007
A
- Psychophysiological insomnia is most common form of persistent primary insomnia
- Behavioural phenotype
- Can be treated effectively using a range of psychological interventions
- Behavioural and cognitive factors play a role
- Explanatory model called the attention-intention-effort pathway
○ Sleep normalcy is an automatic process
§ May be inhibited by focused attentions and direct attempts to control its expression
2
Q
Kyle 2010
A
- Insomnia is a 24h disorder impairing important aspects of daytime functioning
- Little published work describing the impact of insomnia on important areas of functioning or the experience of living with chronically disturbed sleep on a daily basis
- Ppts described daily difficulties with cognitive, emotional, and physical functioning which had a cumulative effect of reducing work performance and social participation as well as limiting life aspirations
- Also described feeling isolated which was precipitated by a lack of understanding from others and experiences with health care providers
- Chronically disturbed sleep can seriously limit overall quality of life.
3
Q
Morin
A
- Psychological and behavioural factors play an important role in insomnia
- Psychological and behavioural therapies produced reliable changes in several sleep parameters of individuals with primary insomnia or insomnia related with medical and psychiatric disorders
- Sleep improvements achieved with treatment were well sustained over time expect in reduced psychological symptoms/distress
- 5 treatments met criteria for empirically supported psychological treatments for insomnia: stimulus control therapy, relaxation, paradoxical intention, sleep restriction, cognitive behaviour therapy
4
Q
NIH
A
- Chronic insomnia is a major public health problem affecting millions of individuals, along with their families and communities.
- Little is known about the mechanisms, causes, clinical course, comorbidities, and consequences of chronic insomnia.
- Evidence supports the efficacy of cognitive-behavioral therapy and benzodiazepine receptor agonists in the treatment of this disorder.
- Very little evidence supports the efficacy of other treatments, despite their widespread use.
- mismatch between the potential lifelong nature of this illness and the longest clinical trials, which have lasted 1 year or less.